Abstract
Mice were infected intracorneally with Mycobacterium tuberculosis var. bovis and the infection allowed to develop for a period of 2 weeks. At this stage the animals were divided into two main groups; one received no treatment, the other was treated with large doses of isoniazid (3.0 mg./mouse/day). The effect of treatment on the primary lesion, the viability of the bacilli, the systemic spread of infection, and the production of immunity were observed. Treatment was continued for 11 months, after which the animals were observed for another 8 months. Within a few days of starting isoniazid treatment the primary lesion stopped increasing in size, regressed slightly and stabilized at a size of about one-third of that of the controls. There was little evidence of any clearing of the bacilli from the lesions; they remained strongly acid-fast and morphologically normal for many months after infection, although by 13 months about half of the organisms in both groups had become very granular. The evidence suggests that in control and treated animals the bacilli in the cornea had usually all died within 8 months after infection. In two treated corneas, living virulent bacilli were demonstrated 15 months after inoculation. In the untreated animals, the disease spread systemically to involve the lungs, liver, and spleen, and by one year after inoculation the systemic tuberculous infection was very heavy, though not enough to kill the animals. The lesions in these animals contained many acid-fast bacilli. In the treated group, systemic spread of infection as judged by the development of small macroscopic lung foci was slight; acid-fast bacilli were found in only one animal. In the treated animals, practically no immunity could be detected 5 months after inoculation and had not reappeared 2 months after cessation of treatment; in the untreated animals immunity was present.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ACHARYA B. K., SULLIVAN F. M., ROBSON J. M. Immunity in experimental tuberculosis. Am Rev Tuberc. 1958 Aug;78(2):203–225. doi: 10.1164/artpd.1958.78.2.203. [DOI] [PubMed] [Google Scholar]
- BOJALIL L. F., PEREZ-TAMAYO R., BASTARRACHEA F. Persistence of tubercle bacilli in the organs of guinea pigs under chemotherapy. Am Rev Tuberc. 1958 Mar;77(3):473–481. doi: 10.1164/artpd.1958.77.3.473. [DOI] [PubMed] [Google Scholar]
- FEREBEE S., MOUNT F. W., ANASTASIADES A. Prophylactic effects of isoniazid on primary tuberculosis in children; a preliminary report. Am Rev Tuberc. 1957 Dec;76(6):942–963. doi: 10.1164/artpd.1957.76.6.942. [DOI] [PubMed] [Google Scholar]
- HOBBY G. L., AUERBACH O., LENERT T. F., SMALL M. J., COMER J. V. The late emergence of M. tuberculosis in liquid cultures of pulmonary lesions resected from humans. Am Rev Tuberc. 1954 Aug;70(2):191–218. doi: 10.1164/art.1954.70.2.191. [DOI] [PubMed] [Google Scholar]
- MCCUNE R. M., Jr, MCDERMOTT W., TOMPSETT R. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J Exp Med. 1956 Nov 1;104(5):763–802. doi: 10.1084/jem.104.5.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MCCUNE R. M., Jr, TOMPSETT R. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J Exp Med. 1956 Nov 1;104(5):737–762. doi: 10.1084/jem.104.5.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- REES R. J. W., ROBSON J. M. Experimental tuberculous infections of the cornea of the mouse; a screening test for anti-tuberculous substances. Br J Pharmacol Chemother. 1950 Mar;5(1):77–86. doi: 10.1111/j.1476-5381.1950.tb00579.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROBSON J. M., DIDCOCK K. A. The effect of isoniazid in experimental corneal tuberculosis. Br J Pharmacol Chemother. 1956 Jun;11(2):190–197. doi: 10.1111/j.1476-5381.1956.tb01052.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROBSON J. M., SULLIVAN F. M. Quantitative studies on the multiplication of tubercle bacilli in vivo. Am Rev Tuberc. 1957 May;75(5):756–767. doi: 10.1164/artpd.1957.75.5.756. [DOI] [PubMed] [Google Scholar]
- SPAIN D. M. Effect of isoniazid on early acute inflammatory response in mice. Proc Soc Exp Biol Med. 1953 Feb;82(2):358–360. doi: 10.3181/00379727-82-20116. [DOI] [PubMed] [Google Scholar]
- STEENKEN W., Jr, WOLINSKY E., PRATT P. C., SMITH M. M. Streptomycin in guinea pigs with discrete chronic tuberculous lesions. Am Rev Tuberc. 1952 Aug;66(2):194–212. doi: 10.1164/art.1952.66.2.194. [DOI] [PubMed] [Google Scholar]